Stock ALXO ALX ONCOLOGY HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts ALX Oncology Holdings Inc.

Equities

ALXO

US00166B1052

Real-time Estimate Cboe BZX
Other stock markets
 03:16:54 2024-05-08 pm EDT 		5-day change 1st Jan Change
16.3 USD -7.15% Intraday chart for ALX Oncology Holdings Inc. -3.90% +9.34%
May. 07 ALX Oncology Appoints Allison Dillon as Chief Business Officer CI
Apr. 30 ALX Oncology Holdings Inc. Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bullish

Bullish

Bullish

Resistance 20.52 23.26 29.35
Spread/Res.-14.42%-24.51%-40.17%
Spread/Supp.+23.40%+60.37%+111.06%
Support 14.23 10.95 8.320

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. ALXO Stock
  4. Charts ALX Oncology Holdings Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW